Brought to you by 
Follow-on offering nets Oncolytics $Cdn3.45mm
05 Dec 2008
Executive Summary
Oncolytics Biotech (developing oncolytic virsues as cancer therapies) netted $Cdn3.45mm ($2.8mm) through a follow-on public offering of 2.5mm common shares at $Cdn1.50 each. Investors also received three-year warrants to purchase 2.5mm shares at $Cdn1.80 apiece.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Follow-on offering nets Oncolytics $Cdn3.45mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice